RankAlpha logo
Back to Rankings

MSLE

Satellos BioscienceF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MSLE vs peer average
24/100
MSLE vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KROS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $202.08M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKROSKeros Therapeutics
MSLE
Satellos Bioscience
KROS
Keros Therapeutics
Grade
F
B
Momentum
0
16
Value
41
44
Sentiment
-
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs KROS

MSLE / KROS
Grade Position
Below peers
MSLE vs. peer average (F vs. C)
24/100
Momentum
0
KROS
Value
41
KROS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MSLE
1
KROS
Keros Therapeutics Inc Common
B
80/100
-3
2
NBP
NovaBridge Biosciences ADR
D
40/100
-1
3
ANIK
Anika Therapeutics Inc Common
A
100/100
-4
4
IMUX
Immunic Inc Common
F
20/100
Even
5
NERV
Minerva Neurosciences Inc Common
B
80/100
-3
KROS is the first peer returned for this comparison set.